0001209191-20-063915.txt : 20201216 0001209191-20-063915.hdr.sgml : 20201216 20201216194613 ACCESSION NUMBER: 0001209191-20-063915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kwan Pui San CENTRAL INDEX KEY: 0001733642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 201393865 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-14 0 0001340652 ChemoCentryx, Inc. CCXI 0001733642 Kwan Pui San C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 Principal Acctg Officer Common Stock 2020-12-14 4 M 0 834 3.57 A 4066 D Common Stock 2020-12-14 4 M 0 6667 6.62 A 10733 D Common Stock 2020-12-14 4 M 0 1456 11.02 A 12189 D Common Stock 2020-12-14 4 S 0 8957 65.0215 D 3232 D Common Stock 2020-12-15 4 M 0 3333 6.62 A 6565 D Common Stock 2020-12-15 4 M 0 10919 11.02 A 17484 D Common Stock 2020-12-15 4 M 0 16675 10.86 A 34159 D Common Stock 2020-12-15 4 M 0 11666 9.04 A 45825 D Common Stock 2020-12-15 4 S 0 42593 65.0632 D 3232 D Stock Option (right to buy) 3.57 2020-12-14 4 M 0 834 D 2026-03-07 Common Stock 834 0 D Stock Option (right to buy) 6.62 2020-12-14 4 M 0 6667 D 2027-02-28 Common Stock 6667 4167 D Stock Option (right to buy) 6.62 2020-12-15 4 M 0 3333 D 2027-02-28 Common Stock 3333 834 D Stock Option (right to buy) 10.86 2020-12-15 4 M 0 16675 D 2028-03-05 Common Stock 16675 18066 D Stock Option (right to buy) 11.02 2020-12-14 4 M 0 1456 D 2029-03-04 Common Stock 1456 39044 D Stock Option (right to buy) 11.02 2020-12-15 4 M 0 10919 D 2029-03-04 Common Stock 10919 28125 D Stock Option (right to buy) 9.04 2020-12-15 4 M 0 11666 D 2029-11-01 Common Stock 11666 28334 D Includes 2,739 shares acquired under the Issuer's employee stock purchase plan since the last date of the reporting person's last ownership report. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $65.00 to $65.18 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $65.00 to $65.40 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. As of December 14, 2020, and prior to this transaction, the exercised options were fully vested. Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2020-12-16